Tigecycline Injection, Powder, Lyophilized, For Solution
Product Images NDC 60505-6098

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tigecycline (NDC 60505-6098). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure 01

Chemical structure of tigecycline, showing its molecular arrangement with multiple rings, hydroxyl groups, and amide functional groups.*

FDA Label Image

Tigecycline-for-injection-carton-label (Tigecycline For Injection Carton Label)

Tigecycline for Injection, USP 50 mg per vial packaging label from Apotex Corp. The label indicates it is for intravenous infusion only and contains 10 single-dose vials. The label includes storage instructions and notes that the reconstituted solution must be further diluted. Manufactured for Apotex Corp with additional manufacturing information listed.*

FDA Label Image

Tigecycline-for-injection-vial-label (Tigecycline For Injection Vial Label)

Tigecycline for Injection, USP 50 mg per vial, lyophilized powder for intravenous infusion only. Single-dose vial label by Apotex Corp. Contains 100 mg lactose monohydrate, pH adjusted with HCl and/or NaOH, with no preservatives. Includes manufacturer and lot/expiration date area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.